Latest Breaking News On - Vor biopharma - Page 2 : comparemela.com

Vor Biopharma (NYSE:VOR) Receives Outperform Rating from Wedbush

Vor Biopharma (NYSE:VOR) Receives Outperform Rating from Wedbush
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Stifel nicolausSecurities exchange commissionVor biopharma incSg americas securitiesVor biopharmaGet free reportBiopharma stock downFree reportBiopharma incVor biopharma daily

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomSarah spencerVor biopharma incCompensation committee of the board directorsCompensation committeeVor bioNasdaq listing ruleVor biopharmaInducement plan

Vor Biopharma s (VOR) Outperform Rating Reiterated at Wedbush

Wedbush reissued their outperform rating on shares of Vor Biopharma (NYSE:VOR – Free Report) in a research report released on Tuesday, Benzinga reports. Wedbush currently has a $11.00 price target on the stock. A number of other equities research analysts have also recently issued reports on the stock. Stifel Nicolaus reduced their target price on […]

Stifel nicolausVor biopharma incExchange traded conceptsSecurities exchange commissionVor biopharmaFree reportBiopharma stock downGet free reportTraded conceptsBiopharma incVor biopharma daily

Wedbush Reiterates Outperform Rating for Vor Biopharma (NYSE:VOR)

Wedbush Reiterates Outperform Rating for Vor Biopharma (NYSE:VOR)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Stifel nicolausVor biopharma company profileExchange traded conceptsExchange commissionVor biopharma incVor biopharmaFree reportBiopharma trading downGet free reportTraded conceptsBiopharma incVor biopharma daily

PureTech Announces Annual Results for Year Ended December 31, 2023

Significant operational and clinical progress in 2023 and early 2024 with maturation of Internal Programs,1 launch of two new Founded Entities,2 including a $100 million Series A financing for.

United kingdomUnited statesCity ofBharatt chowriraLa monte carloDaphne zoharCastro pereiraPirfenidone esbrietEric elenkoMonte carloBristol myers squibbKaruna karRaju kucherlapatiEli lillyStevenm paulRobert langer